Exploring Structural Perturbations Caused by Cancer-Related Mutations in Pyruvate Kinase M2: A Comparison with the

Anandita Mitra1, Sandip Paul1

  • 1Department of Chemistry, Indian Institute of Technology, Guwahati, Assam 781039, India.

Insights

Mutations in pyruvate kinase (PKM2) disrupt its structure, affecting cancer cell function. This study reveals how PKM2 mutations alter protein dynamics and interactions, offering insights into cancer development.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Cancer Biology

Background:

  • Pyruvate kinase (PKM2) is a key glycolytic enzyme often mutated in cancer.
  • Previous research focused on PKM2 mutations' impact on tumor growth, not structural changes.
  • Understanding PKM2 structural dynamics is crucial for cancer research.

Purpose of the Study:

  • To investigate the structural effects of PKM2 mutations on protein architecture.
  • To analyze the impact of mutations on PKM2's dynamic behavior and interaction networks.

Main Methods:

  • Molecular dynamics (MD) simulations were used to study 11 PKM2 mutants.
  • Analysis included root-mean-square fluctuation (RMSF) and principal component analysis (PCA).
  • Interactions, hydrogen bonds, and salt bridges were examined.

Main Results:

  • Six of 11 PKM2 mutants showed significant structural perturbations compared to wild-type (WT).
  • Mutations destabilized the B domain, disrupting its closure towards the A domain.
  • Altered interdomain distances and weakened contacts were observed, impacting active and allosteric sites.

Conclusions:

  • PKM2 mutations impair domain communication and structural stability.
  • These findings provide insights into cancer-related PKM2 structural alterations.
  • The study highlights potential therapeutic targets by understanding PKM2 mutant behavior.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
7.0K
Mismatch Repair01:36

Mismatch Repair

Overview
44.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.5K